No phaseCompletedHealthspan endpoint
Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management (OPTIMOVA)
- Sponsor
- Institut Bergonié (Academic or other)
- Enrolment
- 25 enrolled
- Conditions
- Ovarian Carcinoma
- Interventions
- Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA).
- Ages
- adults, older adults
- Registry
- NCT05415527
Full record on ClinicalTrials.gov
From the registry
Prospective, monocentric study evaluating the presence of sarcopenia prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management.
Primary outcomes
- Proportion of patients with pretreatment sarcopenia identified by analysis of the baseline CT-scan (CT0).
History
Last registry update
Study completion
Primary completion
Registered
Started